Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002252:Carbon Tetrachloride Poisoning; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004558:Electric Stimulation; D006339:Heart Rate / Q000187:drug effects; D007275:Injections, Intravenous; D002040:Levobunolol / Q000008:administration & dosage / Q000494:pharmacology*; D008862:Microsomes, Liver / Q000201:enzymology; D011169:Portal Vein; D011335:Proadifen / Q000494:pharmacology; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D013015:Sotalol / Q000008:administration & dosage / Q000494:pharmacology*; D013237:Stereoisomerism
D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D011335:Proadifen; D013015:Sotalol; D002040:Levobunolol